Galliprant (grapiprant) is a prescription-only tablet for the pain and inflammation of canine osteoarthritis, given once daily at 2 mg/kg (0.9 mg/lb) to dogs at least 9 months old and at least 8 lb. It belongs to a class no other canine arthritis drug uses: it blocks a single prostaglandin receptor (EP4) instead of shutting down cyclooxygenase enzymes the way carprofen and meloxicam do. In its pivotal 28-day trial, 48.1% of treated dogs met the definition of treatment success — against 31.3% of dogs on placebo.
That last number is the one almost every article about this drug leaves out, and it changes how you should read the first one. Below is what the FDA label actually says, what the trials actually measured, the dosing detail most owners get wrong, and where daily joint nutrition fits around a prescription your vet controls.
What Galliprant is, and why its class matters
Galliprant is the brand name for grapiprant, made by Elanco. It is classed as a non-cyclooxygenase-inhibiting NSAID of the piprant family. Traditional NSAIDs block COX enzymes, which reduces prostaglandin production across the body — including the prostaglandins that maintain the stomach lining and kidney blood flow. Grapiprant leaves prostaglandin production intact and instead blocks the EP4 receptor, one of four receptors that PGE2 acts on, and the one most associated with arthritis pain and inflammation.
The commercial story built on that mechanism is that grapiprant is gentler on the stomach, liver and kidneys. The label itself is more careful. It notes that EP4 also has housekeeping roles — gastric and colonic mucus secretion, small-intestinal motility, gastric ulcer healing, and sodium handling in the kidney — and it keeps grapiprant inside the full NSAID class-warning framework, with the same baseline bloodwork and periodic monitoring advice as any other NSAID.
So: a genuinely different mechanism, real regulatory approval, and a marketing claim that runs ahead of the evidence. There is no head-to-head trial of grapiprant against carprofen or meloxicam in chronic canine osteoarthritis. Current research does not strongly prove that it is safer on the kidneys, liver or GI tract in long-term arthritis use.
Galliprant dosage for dogs
| Label item | What the FDA label specifies |
|---|---|
| Dose | 0.9 mg/lb (2 mg/kg) by mouth, once every 24 hours |
| Guidance | Lowest effective dose, for the shortest duration |
| Tablet strengths | 20 mg, 60 mg, 100 mg (pork-liver flavoured) |
| Splitting | Only the 20 mg and 60 mg are scored. The 100 mg must not be split. |
| Minimum weight | Dogs under 8 lb (3.6 kg) cannot be accurately dosed |
| Minimum age | Not evaluated under 9 months |
| Not evaluated in | Breeding, pregnant or lactating dogs; dogs with cardiac disease |
| Hard rule | Never with another oral or injectable NSAID or a corticosteroid. A washout is required when switching. |
The empty-stomach detail most owners miss
Search results routinely say Galliprant can be given "with or without food." The pharmacokinetic data on the label says something sharper: giving the tablet with food reduces peak blood concentration roughly four-fold and total drug exposure roughly two-fold (fed/fasted AUC ratio 0.37). A dog fed at the same time as dosing may be absorbing around a third of the exposure the trial dogs received.
The practical read: give it on an empty stomach unless your vet directs otherwise. The label's own fallback is that if a dog vomits when dosed fasted, the next dose can be given with food or a small treat — accepting the trade-off knowingly rather than by accident. If your dog "isn't responding," this is the first thing worth raising with your vet before anyone concludes the drug failed.
How well does it actually work?
The approval rests on a prospective, randomized, masked, placebo-controlled multisite study by Rausch-Derra and colleagues (J Vet Intern Med 2016;30(3):756-763, PMID 27075237). 285 client-owned dogs were enrolled; 262 were evaluable for effectiveness, split evenly between grapiprant and vehicle control. Dogs received 2 mg/kg once daily for 28 days after a washout from prior arthritis therapy. The outcome was owner scoring on the Canine Brief Pain Inventory.
| Outcome (28 days, CBPI treatment success) | Grapiprant | Vehicle control |
|---|---|---|
| Dogs meeting treatment success | 63 of 131 (48.1%) | 41 of 131 (31.3%) |
| Absolute difference | ~17 percentage points, statistically significant | |
Read honestly, that is a real but moderate effect — and note that roughly a third of dogs on placebo also "succeeded." Owner-reported canine arthritis trials carry a large caregiver placebo response. It is one of the reasons two owners can give the same drug and come away with completely different impressions.
Short-term surgical studies have compared grapiprant to older NSAIDs: a masked randomized noninferiority trial in 42 dogs undergoing ovariohysterectomy supported grapiprant as an analgesic alternative to carprofen (JAVMA 2023;261(1), PMID 36374577), and a preliminary 12-Beagle study pointed the same way while explicitly calling itself underpowered (PMID 35930789). These are acute post-surgical settings over days, not arthritis management over years. They do not transfer.
Galliprant side effects
In the 28-day field study, adverse events in the grapiprant group (n=141) versus vehicle (n=144) were: vomiting 24 vs 9, diarrhea or soft stool 17 vs 13, inappetence 9 vs 7, lethargy 6 vs 2, buccal ulcer 1 vs 0, immune-mediated hemolytic anemia 1 vs 0.
The post-approval experience section of the current label is broader and is worth reading before you decide this drug is in a gentler category than other NSAIDs. Reported events include diarrhea and vomiting with or without blood, melena, GI ulcer, pancreatitis and elevated pancreatic enzymes, hypoalbuminemia, elevated liver enzymes, increased BUN and creatinine, renal failure, ataxia, seizures, anemia, thrombocytopenia, facial edema and hives. The label states plainly that in some cases death, including euthanasia, has been reported as an outcome.
Call your vet the same day if you see
- Vomiting or diarrhea containing blood, or black tarry stool
- Refusing food for more than one meal, or sudden lethargy
- A jump in drinking or urinating, or new incontinence
- Yellowing of the gums or eyes, or pale gums
- Wobbliness, disorientation, or any seizure activity
- Facial swelling, hives, or intense itching
Higher-risk dogs per the label: those that are dehydrated or prone to dehydration, on diuretics, or with existing kidney, cardiovascular or liver disease. Grapiprant is a methylbenzenesulfonamide and cross-reactivity in sulfonamide-sensitive dogs is unknown.
Myth vs label
| Commonly repeated | What the evidence supports |
|---|---|
| "It's not really an NSAID" | It is an NSAID — a non-COX-inhibiting one. It carries full NSAID class warnings and the same monitoring advice. |
| "Safer for kidneys and liver than carprofen" | A mechanistic inference, not a demonstrated outcome. No comparative chronic-OA trial exists; renal failure and hepatic enzyme elevation appear in post-approval reports. |
| "Bloodwork isn't needed since it's gentle" | The label calls for baseline hematology and serum biochemistry and periodic monitoring during use. |
| "It repairs the joint" | The indication is control of pain and inflammation only. No disease-modifying or cartilage-preserving claim is approved. |
| "9-month studies prove long-term safety in arthritic dogs" | The 9-month study used 36 healthy laboratory Beagles, not arthritis patients (Am J Vet Res 2015;76(10):853-859, PMID 26413822). GI signs occurred in every group including controls. |
| "Give it with dinner, it doesn't matter" | Food cuts exposure roughly two-fold. It matters. |
Where daily joint nutrition fits — and what the best evidence says
A prescription NSAID and daily joint nutrition do different jobs. The drug is dosed by your vet to control pain now. Nutrition is the long game around it. Nothing you buy without a prescription replaces grapiprant, and no supplement should ever be used as a reason to change, skip or stop a prescribed dose — that decision belongs to your veterinarian alone.
The most useful reference for choosing between ingredients is a 2022 systematic review and meta-analysis covering 72 canine and feline osteoarthritis trials (Int J Mol Sci 2022;23(18):10384, PMID 36142319). Its conclusions are not the ones the supplement aisle would choose:
| Ingredient class | Verdict in the 2022 meta-analysis |
|---|---|
| Omega-3 (EPA/DHA) diets and supplements | Evident clinical analgesic efficacy — the strongest signal of any nutraceutical reviewed |
| Green-lipped mussel | Promising, but minimal evidence; further clinical study needed |
| Collagen | Weak efficacy |
| Glucosamine + chondroitin | "Very marked non-effect"; the authors recommend they no longer be relied on for OA pain |
We would rather print that table than hide it. It is also the reason our formulas are not built on the glucosamine-and-chondroitin pair alone. Most joint chews on the shelf stop at two or three actives drawn from exactly the category the meta-analysis de-recommends. Our Hip & Joint Chews for Dogs carry 18 active ingredients, and they deliberately include the classes the evidence actually favours — omega-3s and green-lipped mussel for dogs, alongside UC-II undenatured type II collagen, MSM, hyaluronic acid, turmeric at 95% curcumin, boswellia and ginger — rather than stopping where the cheapest formulas stop. Every batch is made in North America to GMP standards with a certificate of analysis, and shipping is free worldwide.
On the NSAID-sparing question owners always ask: there is one relevant controlled trial, and it used a different drug. In 131 client-owned dogs across 33 practices, a fish-oil omega-3-supplemented diet allowed a reduction in carprofen dosage (JAVMA 2010;236(5):535-539, PMID 20187817). That was a therapeutic diet, not a chew, and the NSAID was carprofen. No equivalent study has been done with grapiprant. Current research does not strongly prove that omega-3 supplementation permits a grapiprant dose reduction, and you should not attempt one on your own.
For dogs that spit out chews or need dosing to the drop, liquid glucosamine for dogs is the easier format — already dissolved, mixed straight into food, dosed precisely by weight. You can compare both formats in the dog joint & hip supplements collection, and if you are still deciding what belongs in the bowl at all, start with our guide to the best joint supplements for dogs.
What we will not claim
Our supplements are not a treatment for osteoarthritis, they are not an alternative to Galliprant or any prescription medication, and they have not been studied in combination with grapiprant. Tell your veterinarian about every supplement your dog receives so drug compatibility can be assessed.
A realistic timeline
| Window | What owners commonly report |
|---|---|
| 1–2 hours after a dose | Grapiprant reaches peak blood levels; some owners notice easier movement the first day |
| Week 1 | Most GI side effects, if they appear, show up here. Watch the stool. |
| Week 4 | The point at which the pivotal trial measured its result. A fair moment to review with your vet. |
| Weeks 4–8 (nutrition) | Joint nutrition builds slowly; owners typically report changes in stiffness over this window, not in days |
| Ongoing | Periodic bloodwork per your vet, plus the unglamorous things that outperform every product: weight control, controlled low-impact exercise, traction on slick floors |
Questions worth asking your vet
- Should we take baseline bloodwork before starting, and how often will we recheck?
- Fasted or with food — and if my dog vomits on an empty stomach, what is the plan?
- What washout period applies if we switch from another NSAID or a steroid?
- How will we judge whether it is working, and at what point do we reassess?
- Which supplements can my dog stay on alongside it?
- Is this the right choice versus carprofen for dogs, meloxicam for dogs or Librela for dogs given my dog's kidney values and age?
Frequently asked questions
How long does Galliprant take to work in dogs?
Peak blood concentration is reached within roughly 1–2 hours of a dose, and some owners notice easier movement the same day. The pivotal trial measured its result at 28 days, so a fair assessment of whether it is helping usually takes about four weeks of consistent daily dosing.
Can Galliprant be given with food?
It can, but the label's pharmacokinetic data shows food reduces peak concentration about four-fold and total exposure about two-fold. Fasted dosing is generally preferred. If your dog vomits when dosed on an empty stomach, ask your vet about giving the next dose with a small amount of food.
Can my dog take Galliprant and a joint supplement together?
This combination has not been formally studied, so the honest answer is that your veterinarian has to make that call for your individual dog. Bring the actual product label to the appointment and ask. Never change a prescribed dose because you have added a supplement.
Is Galliprant safer than carprofen or meloxicam?
No head-to-head trial in chronic canine osteoarthritis has been published, so the claim is not established. Grapiprant's mechanism avoids COX inhibition, but the FDA label keeps it under full NSAID class warnings, and post-approval reports include GI ulcer, hepatic enzyme elevation and renal failure. Your vet weighs this against your dog's own bloodwork and history.
Do dogs need bloodwork while on Galliprant?
The label calls for a history and physical exam before starting, baseline hematology and serum biochemistry, and periodic monitoring during administration — with monitoring specifically recommended for long-term use.
Is there an over-the-counter version of Galliprant?
No. Grapiprant is prescription-only in the United States and cannot legally be sold without a veterinarian's order. Joint supplements are a different category entirely — they support daily joint nutrition and are not a substitute for a prescribed medication.
Educational information only — not veterinary advice. Galliprant® and Elanco® are registered trademarks of their respective owners; Pure Majesty Pets is not affiliated with, endorsed by, or sponsored by Elanco. Grapiprant is a prescription medication and decisions about starting, changing or stopping it belong to your veterinarian. Pure Majesty Pets supplements are complementary nutritional products; they have not been evaluated by the FDA or Health Canada to diagnose, treat, cure or prevent any disease. Always consult a licensed veterinarian about your dog's health.